Endovia Health Sciences, Inc. (EDVA) Operating income 2016–2025
Endovia Health Sciences, Inc. (EDVA) annual operating income history from SEC filings — each fiscal year as reported.
-$14.2MFY2025 · since FY2016: -$50,001 → -$14.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$14.2M | -43.3% |
| FY2024 | -$9.9M | +35.2% |
| FY2023 | -$15.3M | +28.5% |
| FY2022 | -$21.4M | +26.4% |
| FY2021 | -$29.1M | -64.7% |
| FY2020 | -$17.7M | -293.6% |
| FY2019 | -$4.5M | -6829.7% |
| FY2018 | $66,675 | +142.4% |
| FY2017 | -$157,206 | -214.4% |
| FY2016 | -$50,001 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EDVA financial trends
EDVA RevenueEDVA Net incomeEDVA Net marginEDVA Gross profitEDVA Gross marginEDVA Operating marginEDVA Operating cash flowEDVA Free cash flowEDVA Capital expendituresEDVA Return on equityEDVA Stock buybacksEDVA Dividends paidEDVA Total assetsEDVA Total liabilitiesEDVA Shareholders’ equityEDVA overview →